Research & Innovation
Advancing cancer care through clinical research
Oklahoma Cancer Specialists and Research Institute integrates clinical research directly into patient care, providing access to advanced therapies and clinical trials that help shape the future of oncology.
Research integrated with care
OCSRI is committed to advancing cancer treatment through participation in clinical trials and research studies. Our physicians and research teams work closely to ensure that eligible patients have access to innovative therapies while receiving high-quality, personalized care.
As a research-focused oncology practice, OCSRI participates in national research networks and collaborates with leading organizations to bring cutting-edge treatments to patients in our community.
Clinical Trials
Explore active research studies
Clinical trials evaluate new approaches to cancer treatment and care. Eligibility varies by diagnosis and treatment history.
Phase III
GS-US-682-6769
A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants with Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy
View detailsPhase III
M24-287
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
View detailsPhase III
A012103
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
View detailsInterested in participating in research?
Clinical trials may be an option depending on diagnosis, treatment history, and eligibility criteria. Our research team can help determine if a study is right for you.
Contact the Research Team